pyrazines has been researched along with arachidonic acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fulton, D; Kaminski, P; McGiff, JC; Quilley, J; Wolin, MS | 1 |
| Aoyagi, Y; Fujitake, M; Hirono, H; Miyata, N; Nishio, T; Ohta, A; Okamoto, K; Suwabe, Y; Suzuki, T; Takahashi, H; Uchino, E; Yamada, K | 1 |
| Barrett, JE; Dunlop, J; Harrison, BL; Mazandarani, H; Rosenzweig-Lipson, S; Sabalski, J; Sabb, A; Stack, G; Welmaker, G; Zhang, J | 1 |
| Kim, SG; Shin, SM | 1 |
| Cho, IJ; Kim, SG; Kwon, YN; Shin, SM | 1 |
| Amo, K; Ito, Y; Koganei, M; Ohminami, H; Orime, K; Sasaki, H; Shirakawa, J; Tajima, K; Takeda, E; Terauchi, Y; Togashi, Y | 1 |
| Abdi, J; Faber, J; Garssen, J; Redegeld, FA | 1 |
| Islam, MS; Jisaka, M; Khan, F; Nartey, MN; Nishimura, K; Rahman, MS; Shono, F; Syeda, PK; Yokota, K | 1 |
| Huang, WJ; Li, JM; Liu, HC; Xie, D; Zhang, YC; Zuo, J | 1 |
| Li, HX; Li, HY; Tian, JH; Wan, X; Zou, Y | 1 |
10 other study(ies) available for pyrazines and arachidonic acid
| Article | Year |
|---|---|
Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat.
Topics: Animals; Arachidonic Acid; Benzimidazoles; Benzopyrans; Bradykinin; Cromakalim; Cyclic N-Oxides; Cytochrome P-450 Enzyme System; Free Radical Scavengers; Heart; Hydrogen Peroxide; Imidazoles; In Vitro Techniques; Indomethacin; Kidney Cortex; Luminescent Measurements; Male; Microsomes; Nitric Oxide; Nitroarginine; Parasympatholytics; Perfusion; Pyrazines; Pyrroles; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; Vasodilator Agents | 1997 |
Anti-platelet aggregation activity of some pyrazines.
Topics: Animals; Arachidonic Acid; Collagen; Drug Evaluation, Preclinical; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Rabbits; Structure-Activity Relationship | 1997 |
Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.
Topics: Animals; Anti-Obesity Agents; Arachidonic Acid; Behavior, Animal; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Eating; Humans; Male; Mice; Mice, Inbred C57BL; Obesity; Phosphoric Monoester Hydrolases; Pyrazines; Quinoxalines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium | 2006 |
Inhibition of arachidonic acid and iron-induced mitochondrial dysfunction and apoptosis by oltipraz and novel 1,2-dithiole-3-thione congeners.
Topics: Apoptosis; Arachidonic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Formazans; Humans; In Situ Nick-End Labeling; Iron; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Pyrazines; Reactive Oxygen Species; Tetrazolium Salts; Thiones; Thiophenes; Time Factors | 2009 |
Oxidized metabolites of oltipraz exert cytoprotective effects against arachidonic acid through AMP-activated protein kinase-dependent cellular antioxidant effect and mitochondrial protection.
Topics: AMP-Activated Protein Kinases; Antioxidants; Apoptosis; Arachidonic Acid; Cytoprotection; Drug Antagonism; Membrane Potential, Mitochondrial; Mitochondria; Pyrazines; Reactive Oxygen Species; Thiones; Thiophenes; Tumor Cells, Cultured | 2009 |
Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased β cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetes.
Topics: Administration, Oral; Animals; Apoptosis; Arachidonic Acid; Diabetes Mellitus; Dietary Carbohydrates; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucokinase; Glucose; Haploinsufficiency; Insulin-Secreting Cells; Linoleic Acid; Male; Mice; Pyrazines; Receptors, Glucagon; Signal Transduction; Sitagliptin Phosphate; Sucrose; Triazoles | 2011 |
Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells.
Topics: Antineoplastic Agents; Apoptosis; Arachidonic Acid; Boronic Acids; Bortezomib; Caspase 3; Cell Line, Tumor; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Gene Expression Regulation; Humans; Leukocytes, Mononuclear; Membrane Potential, Mitochondrial; Mitochondria; Multiple Myeloma; NF-kappa B; Pyrazines | 2014 |
Pretreatment of cultured preadipocytes with arachidonic acid during the differentiation phase without a cAMP-elevating agent enhances fat storage after the maturation phase.
Topics: 1-Methyl-3-isobutylxanthine; 3T3-L1 Cells; 6-Ketoprostaglandin F1 alpha; Acetates; Adipocytes; Adipogenesis; Animals; Arachidonic Acid; Cell Differentiation; Cells, Cultured; Cyclic AMP; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Gene Expression Regulation; Humans; Hydroxyprostaglandin Dehydrogenases; Membrane Proteins; Mesenchymal Stem Cells; Mice; Prostaglandin-E Synthases; Pyrazines; Receptors, Prostaglandin; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Triglycerides | 2016 |
[Synthesis and biological evaluation of novel chalcone aromatic oxygen alkyl acids compounds].
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Chalcones; Hyperlipidemias; Hypolipidemic Agents; Mice, Inbred C57BL; Oxygen; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines | 2016 |
Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents.
Topics: Arachidonic Acid; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Structure-Activity Relationship | 2023 |